TBX1 and CRKL haploinsufficiency is thought to cause the cardiac phenotype of the 22q11.2 deletion syndrome. However, few unequivocal mutations of TBX1 and CRKL have been discovered in isolated conotrucal heart defects (CTDs) patients.
The aim of the study was to screen the mutation of TBX1 and CRKL in isolated CTDs Chinese patients without 22q11.2 deletion and identify the pathomechanism of the missense mutations.
Methods:
We enrolled 199 non-22q11.2 deletion patients with CTDs and 139 unrelated healthy controls. Gene sequencing were performed for all of them.
The functional data of mutations were obtained by in vitro transfection and luciferase experiments and computer modelling.
Results:
Screening of the TBX1 coding sequence identified a de novo missense mutation (c.385G [rightwards arrow] A; p.E129K) and a known polymorphism (c.928G [rightwards arrow] A; p.G310S). In vitro experiments demonstrate that the TBX1E129K variant almost lost transactivation activity.
The TBX1G310S variant seems to affect the interaction of TBX1 with other factors. Computer molecular dynamics simulations showed the de novo missense mutation is likely to affect TBX1-DNA interaction.
No mutation of CRKL gene was found.
Conclusions:
These observations suggest that the TBX1 loss-of-function mutation may be involved in the pathogenesis of isolated CTDs. This is the first human missense mutation showing that TBX1 is a candidate causing isolated CTDs in Chinese patients without 22q11.2 deletion.
Author: Yue-Juan XuSun ChenJian ZhangShao-Hai FangQian-Qian GuoJian WangQi-Hua FuFen LiRang XuKun Sun
Credits/Source: BMC Medical Genetics 2014, 15:78
Published on: 2014-07-06
Tweet
News Provider: 7thSpace Interactive / EUPB Press Office
Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo
There are no comments available. Be the first to write a comment.